Nicholas J Catanzaro

6PUBLICATIONS
105CO-AUTHORS
Phylogeny and comparative analysisMedical molecular engineering of nucleic acids and proteinsCarbon sequestration scienceMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 10, 2026
Clade-3 Bat Sarbecovirus PRD0038 Reveals Constraints on Coronavirus Emergence and Immune Sensitivity.

|Mar 13, 2026
Epitope-focused discovery of SARS-CoV-2 antibodies that potently neutralize Omicron variants.

Seth J Zost, Naveenchandra Suryadevara, Lauren E Williamson

|Oct 15, 2025
Computationally designed mRNA-launched protein nanoparticle immunogens elicit protective antibody and T cell responses in mice.

Grace G Hendricks, Lilit Grigoryan, Mary Jane Navarro

|Oct 09, 2025
Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2.

Siriruk Changrob, Atsuhiro Yasuhara, Suncheol Park

|May 22, 2024
The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.

David R Martinez, Fernando R Moreira, Nicholas J Catanzaro

|Mar 01, 2024
Interferon lambda restricts herpes simplex virus skin disease by suppressing neutrophil-mediated pathology.

Drake T Philip, Nigel M Goins, Nicholas J Catanzaro

Pageof 1

Frequent Collaborators

4 joint publications

Ralph S Baric

3 joint publications

Alexandra Schäfer

2 joint publications

John Powers

2 joint publications

Kendra L Gully